EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group

Stefania Rizzo, Giacomo Avesani, Camilla Panico, Lucia Manganaro, Benedetta Gui, Yulia Lakhman, Pamela Causa Andrieu, Nishat Bharwani, Andrea Rockall, Isabelle Thomassin-Naggara, Teresa Margarida Cunha, Evis Sala und 2 weitere

European Radiology · 11.01.2025 · 35 (7) · 4029-4039

DOI: 10.1007/s00330-024-11300-7 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Radiology, online erschienen am 11.01.2025. Verfasst von Stefania Rizzo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale (EOC), via Tesserete 46, 6900, Lugano, Switzerland. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To provide up-to-date European Society of Urogenital Radiology (ESUR) guidelines for staging and follow-up of patients with ovarian cancer (OC).

Methods

Twenty-one experts, members of the female pelvis imaging ESUR subcommittee from 19 institutions, replied to 2 rounds of questionnaires regarding imaging techniques and structured reporting used for pre-treatment evaluation of OC patients. The results of the survey were presented to the other authors during the group’s annual meeting. The lexicon was aligned with the Society of American Radiology (SAR)-ESUR lexicon; a first draft was circulated, and then comments and suggestions from the other authors were incorporated.

Results

Evaluation of disease extent at diagnosis should be performed by chest, abdominal, and pelvic CT. The radiological report should map the disease with specific mention of sites that may preclude optimal cytoreductive surgery. For suspected recurrence, CT and [ 18 F]FDG PET-CT are both valid options. MRI can be considered in experienced centres, as an alternative to CT, considering the high costs and the need for higher expertise in reporting.

Conclusions

CT is the imaging modality of choice for preoperative evaluation and follow-up in OC patients. A structured radiological report, including specific mention of sites that may preclude optimal debulking, is of value for patient management. Key Points Question Guidelines were last published for ovarian cancer (OC) imaging in 2010; here, guidance on imaging techniques and reporting, incorporating advances in the field, are provided.

Findings

Structured reports should map out sites of disease, highlighting sites that limit cytoreduction. For suspected recurrence, CT and 18FDG PET-CT are options, and MRI can be considered. Clinical relevance Imaging evaluation of OC patients at initial diagnosis (mainly based on CT), using a structured report that considers surgical needs is valuable in treatment selection and planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsHumansFemaleNeoplasm StagingEuropeTomography, X-Ray ComputedSocieties, MedicalMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyFollow-Up Studies

Stichwörter der Autor:innen

Magnetic resonance imagingOvarian cancerPhoton emission computed tomographyStructured reportTomography (x-ray computed)

Autor:innen und Institutionen

  • Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale (EOC), via Tesserete 46, 6900, Lugano, Switzerland.
  • Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), via G. Buffi 13, 6900, Lugano, Switzerland.
  • Department of Imaging and Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. giacomo.avesani@policlinicogemelli.it.
  • Department of Imaging and Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Policlinico Umberto I, Viale del Policlinico 155, 00161, Rome, Italy.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Zitieren

APA

Rizzo, S., Avesani, G., Panico, C., Manganaro, L., Gui, B., Lakhman, Y., Andrieu, P. C., Bharwani, N., Rockall, A., Thomassin-Naggara, I., Cunha, T. M., Sala, E., Forstner, R., & Nougaret, S. (2025). Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group. European Radiology, 35(7), 4029-4039. https://doi.org/10.1007/s00330-024-11300-7

Vancouver

Rizzo S, Avesani G, Panico C, Manganaro L, Gui B, Lakhman Y, et al. Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group. European Radiology. 2025;35(7):4029-4039. doi:10.1007/s00330-024-11300-7

BibTeX
@article{Rizzo2025,
  author = {Rizzo, Stefania and Avesani, Giacomo and Panico, Camilla and Manganaro, Lucia and Gui, Benedetta and Lakhman, Yulia and Andrieu, Pamela Causa and Bharwani, Nishat and Rockall, Andrea and Thomassin-Naggara, Isabelle and Cunha, Teresa Margarida and Sala, Evis and Forstner, Rosemarie and Nougaret, Stephanie},
  title = {Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group},
  journal = {European Radiology},
  year = {2025},
  volume = {35},
  number = {7},
  pages = {4029--4039},
  doi = {10.1007/s00330-024-11300-7}
}
Kostenlos starten →